ADA*2 allele of the adenosine deaminase gene may protect against coronary artery disease

Cardiology

Volumn 108, Issue 4, 2007, Pages 275-281

  Safranow, Krzysztof ^a   Rzeuski, Ryszard ^a   Binczak Kuleta, Agnieszka ^a   Czyzycka, Edyta ^a   Skowronek, Janusz ^a   Jakubowska, Katarzyna ^a   Wojtarowicz, Andrzej ^a   Loniewska, Beata ^a   Ciechanowicz, Andrzej ^a   Kornacewicz Jach, Zdzislawa ^a   Chlubek, Dariusz ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Adenosine purine derivatives; Angiotensin converting enzyme inhibitors; Brain natriuretic peptide; Congestive heart failure; Coronary artery disease

Indexed keywords

ADENOSINE DEAMINASE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; GENE ACTIVITY; GENE FREQUENCY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; NUCLEOTIDE SEQUENCE; POLAND; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE; WILD TYPE; AGED; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

ADENOSINE DEAMINASE; ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, NEWBORN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 36249010424     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099096     Document Type: Article

References (27)

1. Cristalli G, Costanzi S, Lambertucci C, Lupidi G, Vittori S, Volpini R, Camaioni E: Adenosine deaminase: functional implications and different classes of inhibitors. Med Res Rev 2001;21:105-128.
2. Moriwaki Y, Yamamoto T, Higashino K: Enzymes involved in purine metabolism-a review of histochemical localization and functional implications. Histol Histopathol 1999;14:1321-1340.
3. Franco R, Casado V, Ciruela F, Saura C, Mallol J, Canela EI, Lluis C: Cell surface adenosine deaminase: much more than an ectoenzyme. Prog Neurobiol 1997;52:283-294.
4. Hirschhorn R, Yang DR, Israni A: An Asp8Asn substitution results in the adenosine deaminase (ADA) genetic polymorphism (ADA 2 allozyme): occurrence on different chromosomal backgrounds and apparent intragenic crossover. Ann Hum Genet 1994;58:1-9.
5. Battistuzzi G, Iudicone P, Santolamazza P, Petrucci R: Activity of adenosine deaminase allelic forms in intact erythrocytes and in lymphocytes. Ann Hum Genet 1981;45:15-19.
6. Weissmann J, Vollmer M, Pribilla O: Survey of the distribution of adenosine deaminase and superoxide dismutase markers in different populations. Hum Hered 1982;32:344-356.
7. Barankiewicz J, Danks AM, Abushanab E, Makings L, Wiemann T, Wallis RA, Pragnacharyulu PV, Fox A, Marangos PJ: Regulation of adenosine concentration and cytoprotective effects of novel reversible adenosine deaminase inhibitors. J Pharmacol Exp Ther 1997;283:1230-1238.
8. Loh E, Rebbeck TR, Mahoney PD, DeNofrio D, Swain JL, Holmes EW: Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. Circulation 1999;99:1422-1425.
9. Anderson JL, Habashi J, Carlquist JF, Muhlestein JB, Horne BD, Bair TL, Pearson RR, Hart N: A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease. J Am Coll Cardiol 2000;36:1248-1252.
10. Guo SW, Thompson EA: Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992;48:361-372.
11. Bottini E, Gloria-Bottini F: Adenosine deaminase and body mass index in non-insulin-dependent diabetes mellitus. Metabolism 1999;48:949-951.
12. Bottini N, De Luca D, Saccucci P, Fiumara A, Elia M, Porfirio MC, Lucarelli P, Curatolo P: Autism: evidence of association with adenosine deaminase genetic polymorphism. Neurogenetics 2001;3:111-113.
13. Bottini N, Gloria-Bottini F, Amante A, Saccucci P, Bottini E: Genetic polymorphism and Th1/Th2 orientation. Int Arch Allergy Immunol 2005;138:328-333.
14. Nicotra M, Bottini N, Grasso M, Gimelfarb A, Lucarini N, Cosmi E, Bottini E: Adenosine deaminase and human reproduction: a comparative study of fertile women and women with recurrent spontaneous abortion. Am J Reprod Immunol 1998;39:266-270.
15. Jackson EK, Koehler M, Mi Z, Dubey RK, Tofovic SP, Carcillo JA, Jones GS: Possible role of adenosine deaminase in vaso-occlusive diseases. J Hypertens 1996;14:19-29.
16. Moskvina V, Holmans P, Schmidt KM, Craddock N: Design of case-controls studies with unscreened controls. Ann Hum Genet 2005;69:566-576.
17. Willems L, Ashton KJ, Headrick JP: Adenosine-mediated cardioprotection in the aging myocardium. Cardiovasc Res 2005;66:245-255.
18. Kitakaze M, Minamino T, Node K, Takashima S, Funaya H, Kuzuya T, Hori M: Adenosine and cardioprotection in the diseased heart. Jpn Circ J 1999;63:231-243.
19. Miura T, Tsuchida A: Adenosine and preconditioning revisited. Clin Exp Pharmacol Physiol 1999;26:92-99.
20. Ciruela F, Saura C, Canela EI, Mallol J, Lluis C, Franco R: Adenosine deaminase affects ligand-induced signalling by interacting with cell surface adenosine receptors. FEBS Lett 1996;380:219-223.
21. Heusch G, Schulz R: Endogenous protective mechanisms in myocardial ischemia: hibernation and ischaemic preconditioning. Am J Cardiol 1997;80:26A-33A.
22. Lankford AR, Yang JN, Rose'Meyer R, French BA, Matherne GP, Fredholm BB, Yang Z: Effect of modulating cardiac A1 adenosine receptor expression on protection with ischaemic preconditioning. Am J Physiol Heart Circ Physiol 2006;290:H1469-H1473.
23. Hayes ES: Adenosine receptors and cardiovascular disease: the adenosine-1 receptor (A1) and A1 selective ligands. Cardiovasc Toxicol 2003;3:71-88.
24. McCallion K, Harkin DW, Gardiner KR: Role of adenosine in immunomodulation: review of the literature. Crit Care Med 2004;32:273-277.
25. Alsene K, Deckert J, Sand P, de Wit H: Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 2003;28:1694-1702.
26. Hamilton SP, Slager SL, De Leon AB, Heiman GA, Klein DF, Hodge SE, Weissman MM, Fyer AJ, Knowles JA: Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology 2004;29:558-565.
27. Retey JV, Adam M, Honegger E, Khatami R, Luhmann UF, Jung HH, Berger W, Landolt HP: A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans. Proc Natl Acad Sci USA 2005;102:15676-15681.